The global microfluidic devices market was valued at US$ 5.1 Bn in 2020, and is estimated to surge at a CAGR of 24% during the forecast period of 2021-2031. The market in the European region is expected to expand at a reasonable CAGR of around 14%, with global demand expected to reach US$ 21.5 Bn by the end of 2031.
Request For Free Sample Report of “Microfluidic Devices Market”@ https://www.persistencemarketresearch.com/samples/2995
Globally, the microfluidic devices market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare.
Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array. Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices.
In North America, rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Usage of microfluidic technology in North America is high compared to other regions of the world due to its early adoption and multiple applications in different industries.
In Europe, the microfluidic devices market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of microfluidic devices in the region.
However, Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems. Asia is one of the producers of generic drugs, which require microfluidic devices for toxicity testing of drugs.
Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Agilent Technologies, Bio-Rad Laboratories, Inc, Fluidigm Corporation and Johnson & Johnson are some of the major players of microfluidic devices market.
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/2995
The microfluidic devices market is segmented as follows:
Microfluidic Devices Market by Material
- Glass
- Polymer
- Silicon
Microfluidic Devices Market by Application
- Clinical and veterinary diagnostics
- Point of care testing
- Pharmaceutical and life science research
- Drug delivery
- Analytical devices
- Environment and industrial
Microfluidic Devices Market by Industry
- In-vitro diagnostics
- Pharmaceuticals
- Medical devices
Request Customization @ https://www.persistencemarketresearch.com/request-customization/2995
Key Questions Answered in This Report.
- What are the Roadblocks for Microfluidic Devices Market Suppliers?
- What are the Key Opportunities for Microfluidic Devices Market Manufacturers?
- How is Focus on Safety Influencing Microfluidic Devices Market Demand?
- What is the Regulatory Impact on Global Sales of Microfluidic Devices Market?
- Which Region Offers the Largest Opportunity for Sales of Microfluidic Devices Market?
- Where Does the U.S. Stand in the Market for Microfluidic Devices Market?
- What Is the Outlook for Microfluidic Devices Market Manufacturers in China?
- Why is Germany a Lucrative Market for Microfluidic Devices Market Manufacturers?
- Why Will Belgium Outpace Other European Markets for Microfluidic Devices Market?
- Why is There High Demand for Tires in Microfluidic Devices Market?
- Why are Sales of Microfluidic Devices Market Surging?
Related Market Research Reports:
Global Bioinformatics Market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020..
Nano Healthcare Technology for Medical Equipment Market
Global Nano healthcare technology for medical equipment market is anticipated to grow at a stellar CAGR throughout the period of assessment of 2017-2022 to reach a value of about US$ 9.2 Bn.
Antibody Library Technology Market
The global antibody library technologies market segment is anticipated to registering a cagr of 5.0% during the forecast period 2020 to 2030.
Radiology Information Systems Market
Global Radiology Information Systems (RIS) Market – check share, size, revenue, CAGR, regional outlook, key players, competitive landscape, top manufacturers & forecast period.
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.
